ARTICLE | Company News
BioNovion, Genmab deal
March 2, 2015 8:00 AM UTC
Genmab partnered with BioNovion to co-develop and co-commercialize bispecific antibodies targeting immune checkpoints. Both companies will contribute panels of antibodies to create the candidates usin...